To help hospitals and health systems meet demand during the current surge in respiratory illnesses for fever-reducing products to treat pediatric patients and adults unable to swallow solid oral dosage forms, the Food and Drug Administration Friday released guidance for outsourcing facilities compounding certain ibuprofen oral suspension products.
While state-level reimbursement for such costs is not new, it is rarely sufficient to pay the bills. Most offer tax deductions for expenses up to $5,000 or $10,000.
A national shortage of children's Tylenol and Motrin spurred by the surge in respiratory illnesses late last year continues to frustrate Massachusetts families and providers.
Two of the biggest pharmacy chains in the country are planning to seek the certification needed to dispense abortion pills in the states where it is legal, according to spokespeople for the companies.